Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 9 of 16
Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics
NCT03220776
N-Acetylcysteine for Youth Cannabis Use Disorder
NCT03055377
Effects of Neuromodulation and Rehabilitation of the Locomotor Network in Freezing of Gait
NCT03273270
RTMS for Treatment of Pain and Craving
NCT03310138
Oxytocin, Alcohol Craving, and Intimate Partner Aggression
NCT03046836
Gain-framed Messages and NRT for Lung Cancer Screening Patients
NCT03069924
Pilot Study of Pre-Ischemic Conditioning for Intracranial Atherosclerosis
NCT03208166
AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy
NCT03092635
Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer
NCT03021993
LYmphangiogenesis FacTors in Heart Failure States
NCT03141567
Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients
NCT02953873
Patient Centered Health Technology Medication Adherence Program for African American Hypertensives
NCT03454308
CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue
NCT03149094
Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
NCT03171194
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117
VOLtage-based Contrast Media AdaptatioN in Coronary Computed Tomography Angiography
NCT03179592
Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.
NCT03069937
Varenicline Treatment for Cannabis Use Disorder
NCT02892110
Developing rTMS Treatment Strategies for Pain in Opiate Dependence
NCT03576781
Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis
NCT02947087
Functional Viability Duck Duck Punch
NCT03053492
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
NCT02946996
Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients
NCT02954198
Study of Low Field Magnetic Stimulation (LFMS) on Measures of Sleep
NCT03050372
Feasibility Trial of rTMS for Cannabis Use Disorder
NCT03538288
Tension Tamer Randomized Control Trial
NCT03168789
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
NCT02966873
NAC for Treating Comorbid PTSD and SUD
NCT02911285
Improving Evidence-Based Care for Cancer Patients
NCT03207594
TMS for Adults With Autism and Depression
NCT02939560
N-acetylcysteine for Tobacco Use Disorder
NCT02737358
A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I
NCT03069430
10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence
NCT03238859
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
NCT02908932
Enhancing Kidney Donation Through Live Organ Video Educated Donors (LOVED) Study Phase
NCT03599102
Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy
NCT02772562
Learning Enhancement Through Neurostimulation in Autism
NCT02998684
Program for Pain & Prescription Opioid Use in Pregnancy
NCT02804152
Transcranial Direct Current Stimulation (tDCS) and Task-Specific Practice for Post-stroke Neglect
NCT02892097
Comparison of Propofol and Sevoflurane as a Primary Anesthetic for Cardiac Ablation of Atrial Fibrillation.
NCT02697448
Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD
NCT02755103
Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence
NCT02344251
LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
NCT02631772
Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients
NCT02864355
Crossover Study From Macitentan or Bosentan Over to Ambrisentan
NCT02885012
Translational Neuropsychopharmacology Research of Nicotine Addiction
NCT02723162
Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive Control
NCT02949934
Acute Aerobic Exercise and Neuroplasticity in Depression
NCT02839837
Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper
NCT02737826
Smart Phone Medication Adherence Saves Kidneys--SMASK
NCT02827695
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.